Alembic Pharma gets USFDA nod to market generic cancer drug
The company has received approval from the US Food Drug Administration (USFDA) to market Docetaxel Injection in multiple dose vials, the drug maker said in a statement.
Latest News from Moneycontrol.com
How Animated Explainer Videos Communicate Ideas Visually
Lightning Safety Planning for Homeowners and Families












